NU7441 is more potent and specific than NU7026 with IC50 values against DNA-PKcs and PI3K of 14 nM and 5 μM, respectively, [49, 50] and possesses more favorable pharmacokinetic characteristics leading to an improved residence time in the tumor [26]. Here, PRKDC is linked to neoplasm.